Blog
RSS FeedPosted by Michael Wonder on 05 Oct 2019
Is Congress too afraid to fight big pharma?
4 October 2019 - Millions of Americans are struggling to afford their prescription drugs. Big Pharma corporations are enjoying billions ...
Posted by Michael Wonder on 04 Oct 2019
Japan drug price reforms risk hurting investment: Bristol-Myers CEO
3 October 2019 - Japan’s “overly restrictive” drug pricing policies risk diverting foreign direct investment to China and other markets, ...
Posted by Michael Wonder on 03 Oct 2019
White House insists drug prices are falling, but critics say its report is flawed
3 October 2019 - In a bid to seize the narrative on prescription drug pricing, the White House issued a ...
Posted by Michael Wonder on 03 Oct 2019
An unconventional health care speech: Trump wishes pharma stocks would drop, and implies drug industry is behind impeachment
3 October 2019 - President Trump is back in attack mode — and drug companies are again a clear target. ...
Posted by Michael Wonder on 03 Oct 2019
Drug firms 'colluded' to overcharge NHS by up to 1,800%
3 October 2019 - Three drug manufactures broke competition law by colluding to illegally boost the price of a vital ...
Posted by Michael Wonder on 03 Oct 2019
Pelosi's plan to slash drug prices will backfire
2 October 2019 - Yes, prescription medicine costs too much. But stealth government price-setting isn’t the answer. ...
Posted by Michael Wonder on 02 Oct 2019
Trump and Pelosi aides talk drug costs despite impeachment
2 October 2019 - Even as the impeachment battle rumbled, senior White House and Democratic aides sat down Tuesday to ...
Posted by Michael Wonder on 02 Oct 2019
Trump says Pelosi’s promise to work with him on drug price plan is ‘camouflage’ for impeachment
2 October 2019 - Trump is accusing Pelosi of trying to distract voters from the impeachment inquiry with promises to work ...
Posted by Michael Wonder on 02 Oct 2019
The real impact of drug price legislation on biopharmaceutical R&D
2 October 2019 - As outcry around drug prices rages, arguments continue to surface that limiting corporate revenues via price controls ...
Posted by Michael Wonder on 02 Oct 2019
Trade agreement drug monopoly is obsolete given faster, better drug discovery
2 October 2019 - For decades, the brand-name drug industry has relentlessly promoted the message that any reduction in its ...
Posted by Michael Wonder on 01 Oct 2019
Pelosi’s drug pricing plan could wipe out some key funding for low income hospitals
30 September 2019 - A 60 word provision tucked into Nancy Pelosi’s signature drug pricing plan could wreak havoc on ...
Posted by Michael Wonder on 01 Oct 2019
Why transparency in drug pricing is more complicated than it seems
1 October 2019 - Transparency has become a prominent topic in debates about health care, particularly when it comes to ...
Posted by Michael Wonder on 01 Oct 2019
Variation in prescription drug prices by retail pharmacy type: a national cross-sectional study
1 October 2019 - Cash prices for prescription drugs vary widely in the United States. ...
Posted by Michael Wonder on 30 Sep 2019
1 October 2019 price disclosure confirmed prices
30 September 2019 - Confirmed 1 October 2019 prices resulting from the 2019 October Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 30 Sep 2019
Can Washington deliver on drug costs amid impeachment probe?
29 September 2019 - Major legislation to reduce prescription drug costs for millions of people may get sidelined now that House ...